SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001501134-24-000007
Filing Date
2024-01-22
Accepted
2024-01-22 07:05:11
Documents
14
Period of Report
2024-01-17
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 2.05: Cost Associated with Exit or Disposal Activities
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K nvta-20240117.htm   iXBRL 8-K 39037
2 EX-99.1 a20240122-pressrelease.htm EX-99.1 9146
6 nvta-20240117_g1.jpg GRAPHIC 36208
  Complete submission text file 0001501134-24-000007.txt   271605

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT nvta-20240117.xsd EX-101.SCH 1901
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT nvta-20240117_lab.xml EX-101.LAB 23834
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT nvta-20240117_pre.xml EX-101.PRE 12508
8 EXTRACTED XBRL INSTANCE DOCUMENT nvta-20240117_htm.xml XML 2713
Mailing Address 1400 16TH STREET SAN FRANCISCO CA 94103
Business Address 1400 16TH STREET SAN FRANCISCO CA 94103 (415) 374-7782
Invitae Corp (Filer) CIK: 0001501134 (see all company filings)

IRS No.: 271701898 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36847 | Film No.: 24547072
SIC: 8071 Services-Medical Laboratories
(CF Office: 08 Industrial Applications and Services)